{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:14:53Z","timestamp":1786482893327,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.ppat.1011514","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000}}],"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1ZIAAI001180"],"award-info":[{"award-number":["1ZIAAI001180"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["1ZIAAI005003"],"award-info":[{"award-number":["1ZIAAI005003"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["1ZIAAI005143"],"award-info":[{"award-number":["1ZIAAI005143"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Despite the availability of seasonal vaccines and antiviral medications, influenza virus continues to be a major health concern and pandemic threat due to the continually changing antigenic regions of the major surface glycoprotein, hemagglutinin (HA). One emerging strategy for the development of more efficacious seasonal and universal influenza vaccines is structure-guided design of nanoparticles that display conserved regions of HA, such as the stem. Using the H1 HA subtype to establish proof of concept, we found that tandem copies of an alpha-helical fragment from the conserved stem region (helix-A) can be displayed on the protruding spikes structures of a capsid scaffold. The stem region of HA on these designed chimeric nanoparticles is immunogenic and the nanoparticles are biochemically robust in that heat exposure did not destroy the particles and immunogenicity was retained. Furthermore, mice vaccinated with H1-nanoparticles were protected from lethal challenge with H1N1 influenza virus. By using a nanoparticle library approach with this helix-A nanoparticle design, we show that this vaccine nanoparticle construct design could be applicable to different influenza HA subtypes. Importantly, antibodies elicited by H1, H5, and H7 nanoparticles demonstrated homosubtypic and heterosubtypic cross-reactivity binding to different HA subtypes. Also, helix-A nanoparticle immunizations were used to isolate mouse monoclonal antibodies that demonstrated heterosubtypic cross-reactivity and provided protection to mice from viral challenge via passive-transfer. This tandem helix-A nanoparticle construct represents a novel design to display several hundred copies of non-trimeric conserved HA stem epitopes on vaccine nanoparticles. This design concept provides a new approach to universal influenza vaccine development strategies and opens opportunities for the development of nanoparticles with broad coverage over many antigenically diverse influenza HA subtypes.<\/jats:p>","DOI":"10.1371\/journal.ppat.1011514","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:32:49Z","timestamp":1693229569000},"page":"e1011514","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes"],"prefix":"10.1371","volume":"19","author":[{"given":"Dustin M.","family":"McCraw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory L.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu M.","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Maldonado-Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udana","family":"Torian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubza","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Boyoglu-Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-1874","authenticated-orcid":true,"given":"Audray K.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"issue":"Supplement_1","key":"ppat.1011514.ref001","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/infdis\/jiy728","article-title":"Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic","volume":"219","author":"DM Morens","year":"2019","journal-title":"The Journal of infectious diseases"},{"issue":"6","key":"ppat.1011514.ref002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"MM Cox","year":"2008","journal-title":"Influenza and other respiratory viruses"},{"key":"ppat.1011514.ref003","first-page":"181","article-title":"Live attenuated influenza vaccine","volume":"386","author":"H Jin","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"ppat.1011514.ref004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CVI.00085-16","article-title":"Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms","volume":"23","author":"DM McCraw","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"44","key":"ppat.1011514.ref005","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1016\/j.vaccine.2011.07.128","article-title":"Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok(R)) against influenza in healthy adults: a randomized, placebo-controlled trial","volume":"29","author":"JJ Treanor","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"ppat.1011514.ref006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM197703102961012","article-title":"Influenza vaccine: split-product versus whole-virus types\u2014How do they differ","volume":"296","author":"PA Gross","year":"1977","journal-title":"N Engl J Med"},{"issue":"6","key":"ppat.1011514.ref007","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.72.6.729","article-title":"The Antigenic Potency of Epidemic Influenza Virus Following Inactivation by Ultraviolet Radiation","volume":"72","author":"JE Salk","year":"1940","journal-title":"J Exp Med"},{"issue":"4","key":"ppat.1011514.ref008","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4049\/jimmunol.96.4.596","article-title":"Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus","volume":"96","author":"RG Webster","year":"1966","journal-title":"J Immunol"},{"issue":"Suppl 4","key":"ppat.1011514.ref009","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"NM Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"ppat.1011514.ref010","first-page":"301","article-title":"Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin","volume":"386","author":"F Krammer","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"ppat.1011514.ref011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Y Wu","year":"2014","journal-title":"Trends in microbiology"},{"issue":"7554","key":"ppat.1011514.ref012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature14348","article-title":"Dissemination, divergence and establishment of H7N9 influenza viruses in China","volume":"522","author":"TT Lam","year":"2015","journal-title":"Nature"},{"issue":"4","key":"ppat.1011514.ref013","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.vaccine.2017.11.083","article-title":"Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008\u20132012","volume":"36","author":"BF Hibbs","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"ppat.1011514.ref014","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jps.23848","article-title":"Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage","volume":"103","author":"JM Hickey","year":"2014","journal-title":"Journal of pharmaceutical sciences"},{"issue":"9","key":"ppat.1011514.ref015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1503\/cmaj.1041565","article-title":"Preventing cold chain failure: vaccine storage and handling","volume":"171","author":"E Weir","year":"2004","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"issue":"37","key":"ppat.1011514.ref016","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"SJ Gamblin","year":"2010","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"ppat.1011514.ref017","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"NL Kallewaard","year":"2016","journal-title":"Cell"},{"issue":"3","key":"ppat.1011514.ref018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81771-7","article-title":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation","volume":"95","author":"J Chen","year":"1998","journal-title":"Cell"},{"issue":"5796","key":"ppat.1011514.ref019","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"IA Wilson","year":"1981","journal-title":"Nature"},{"issue":"11","key":"ppat.1011514.ref020","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1172\/JCI122895","article-title":"Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance","volume":"128","author":"STH Liu","year":"2018","journal-title":"The Journal of clinical investigation"},{"issue":"Supplement_1","key":"ppat.1011514.ref021","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/jiy696","article-title":"Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens","volume":"219","author":"SJ Zost","year":"2019","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"ppat.1011514.ref022","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"E Kirkpatrick","year":"2018","journal-title":"Scientific reports"},{"issue":"6","key":"ppat.1011514.ref023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15585\/mmwr.mm6806a2","article-title":"Interim Estimates of 2018\u201319 Seasonal Influenza Vaccine Effectiveness\u2014United States, February 2019","volume":"68","author":"JD Doyle","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ppat.1011514.ref024","article-title":"A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases","author":"EJ Erbelding","year":"2018","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ppat.1011514.ref025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The Pathway to a Universal Influenza Vaccine","volume":"47","author":"CI Paules","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"ppat.1011514.ref026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acsinfecdis.5b00146","article-title":"Universal Influenza Vaccines: To Dream the Possible Dream?","volume":"2","author":"JK Park","year":"2016","journal-title":"ACS infectious diseases"},{"issue":"6044","key":"ppat.1011514.ref027","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"DC Ekiert","year":"2011","journal-title":"Science"},{"issue":"12","key":"ppat.1011514.ref028","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1214913110","article-title":"Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies","volume":"110","author":"AK Harris","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6254","key":"ppat.1011514.ref029","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"A Impagliazzo","year":"2015","journal-title":"Science"},{"issue":"3","key":"ppat.1011514.ref030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses","volume":"166","author":"MG Joyce","year":"2016","journal-title":"Cell"},{"issue":"3","key":"ppat.1011514.ref031","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"M Kanekiyo","year":"2019","journal-title":"Nature immunology"},{"issue":"7456","key":"ppat.1011514.ref032","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"M Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"4","key":"ppat.1011514.ref033","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"F Krammer","year":"2014","journal-title":"J Virol"},{"issue":"12","key":"ppat.1011514.ref034","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"F Krammer","year":"2013","journal-title":"J Virol"},{"issue":"9","key":"ppat.1011514.ref035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"HM Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"ppat.1011514.ref036","article-title":"Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance","volume":"93","author":"YQ Chen","year":"2019","journal-title":"J Virol"},{"issue":"2","key":"ppat.1011514.ref037","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DJ DiLillo","year":"2016","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ppat.1011514.ref038","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DJ DiLillo","year":"2014","journal-title":"Nat Med"},{"issue":"6100","key":"ppat.1011514.ref039","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"C Dreyfus","year":"2012","journal-title":"Science"},{"issue":"5924","key":"ppat.1011514.ref040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"DC Ekiert","year":"2009","journal-title":"Science"},{"issue":"42","key":"ppat.1011514.ref041","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"W He","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"ppat.1011514.ref042","first-page":"E5944","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"PE Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1011514.ref043","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy","volume":"162","author":"TT Wang","year":"2015","journal-title":"Cell"},{"key":"ppat.1011514.ref044","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","article-title":"A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release","volume":"17","author":"S Yamayoshi","year":"2017","journal-title":"EBioMedicine"},{"issue":"6044","key":"ppat.1011514.ref045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"D Corti","year":"2011","journal-title":"Science"},{"issue":"7531","key":"ppat.1011514.ref046","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13764","article-title":"Rapid development of broadly influenza neutralizing antibodies through redundant mutations","volume":"516","author":"L Pappas","year":"2014","journal-title":"Nature"},{"issue":"2","key":"ppat.1011514.ref047","first-page":"e00257","article-title":"Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate","volume":"7","author":"EE Tran","year":"2016","journal-title":"MBio"},{"issue":"1","key":"ppat.1011514.ref048","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02810-18","article-title":"Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages","volume":"10","author":"KS Corbett","year":"2019","journal-title":"MBio"},{"issue":"25","key":"ppat.1011514.ref049","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"VV Mallajosyula","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1011514.ref050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41541-017-0036-2","article-title":"Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines","volume":"2","author":"TC Sutton","year":"2017","journal-title":"NPJ vaccines"},{"key":"ppat.1011514.ref051","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"SA Valkenburg","year":"2016","journal-title":"Scientific reports"},{"issue":"21","key":"ppat.1011514.ref052","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.1128\/JVI.01694-12","article-title":"A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin","volume":"86","author":"A Schneemann","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"ppat.1011514.ref053","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"D Cucinotta","year":"2020","journal-title":"Acta bio-medica: Atenei Parmensis"},{"issue":"6478","key":"ppat.1011514.ref054","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.367.6478.610","article-title":"Will novel virus go pandemic or be contained?","volume":"367","author":"K Kupferschmidt","year":"2020","journal-title":"Science"},{"issue":"253","key":"ppat.1011514.ref055","doi-asserted-by":"crossref","first-page":"253ps10","DOI":"10.1126\/scitranslmed.3009872","article-title":"Emerging viral diseases: confronting threats with new technologies","volume":"6","author":"HD Marston","year":"2014","journal-title":"Science translational medicine"},{"issue":"12","key":"ppat.1011514.ref056","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1128\/JVI.02975-12","article-title":"Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin","volume":"87","author":"C Dreyfus","year":"2013","journal-title":"J Virol"},{"issue":"24","key":"ppat.1011514.ref057","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1128\/JVI.77.24.12950-12960.2003","article-title":"Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins","volume":"77","author":"M Newman","year":"2003","journal-title":"J Virol"},{"issue":"1\u20132","key":"ppat.1011514.ref058","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijmm.2007.08.002","article-title":"Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines","volume":"298","author":"M Nassal","year":"2008","journal-title":"International journal of medical microbiology: IJMM"},{"issue":"3","key":"ppat.1011514.ref059","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jmb.2005.10.035","article-title":"Epitope diversity of hepatitis B virus capsids: quasi-equivalent variations in spike epitopes and binding of different antibodies to the same epitope","volume":"355","author":"A Harris","year":"2006","journal-title":"Journal of molecular biology"},{"issue":"1","key":"ppat.1011514.ref060","article-title":"Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A\/H1N1pdm Virus","volume":"9","author":"JK Park","year":"2018","journal-title":"MBio"},{"key":"ppat.1011514.ref061","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1038\/ncomms12041","article-title":"Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles","volume":"7","author":"L He","year":"2016","journal-title":"Nature communications"},{"issue":"5","key":"ppat.1011514.ref062","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"M Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"ppat.1011514.ref063","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coi.2019.03.003","article-title":"Protein engineering and particulate display of B-cell epitopes to facilitate development of novel vaccines","volume":"59","author":"Z Xu","year":"2019","journal-title":"Current opinion in immunology"},{"issue":"8","key":"ppat.1011514.ref064","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"DM Smith","year":"2013","journal-title":"Nature reviews Immunology"},{"issue":"5","key":"ppat.1011514.ref065","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells","volume":"50","author":"W Bu","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"ppat.1011514.ref066","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus","volume":"176","author":"J Marcandalli","year":"2019","journal-title":"Cell"},{"issue":"10","key":"ppat.1011514.ref067","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrmicro2872","article-title":"Understanding and learning from the success of prophylactic human papillomavirus vaccines","volume":"10","author":"JT Schiller","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"ppat.1011514.ref068","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0065-3527(05)64005-5","article-title":"Structure, assembly, and antigenicity of hepatitis B virus capsid proteins","volume":"64","author":"AC Steven","year":"2005","journal-title":"Advances in virus research"},{"issue":"6","key":"ppat.1011514.ref069","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"SA Wynne","year":"1999","journal-title":"Molecular cell"},{"issue":"6297","key":"ppat.1011514.ref070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.aaf8818","article-title":"Accurate design of megadalton-scale two-component icosahedral protein complexes","volume":"353","author":"JB Bale","year":"2016","journal-title":"Science"},{"key":"ppat.1011514.ref071","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.77.062906.171838","article-title":"Macromolecular modeling with rosetta","volume":"77","author":"R Das","year":"2008","journal-title":"Annual review of biochemistry"},{"issue":"7610","key":"ppat.1011514.ref072","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nature18010","article-title":"Design of a hyperstable 60-subunit protein dodecahedron. [corrected]","volume":"535","author":"Y Hsia","year":"2016","journal-title":"Nature"},{"issue":"6158","key":"ppat.1011514.ref073","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"JS McLellan","year":"2013","journal-title":"Science"},{"issue":"6136","key":"ppat.1011514.ref074","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"JS McLellan","year":"2013","journal-title":"Science"},{"issue":"Suppl 1","key":"ppat.1011514.ref075","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1017\/S1431927618007092","article-title":"Conserved Structural Anatomy Between Divergent Viral Capsid Nanoparticles for Vaccine Design","volume":"24","author":"DM McCraw","year":"2018","journal-title":"Microsc Microanal"},{"issue":"8","key":"ppat.1011514.ref076","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.vaccine.2010.12.120","article-title":"Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain","volume":"29","author":"A Farnsworth","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"ppat.1011514.ref077","doi-asserted-by":"crossref","first-page":"e0202300","DOI":"10.1371\/journal.pone.0202300","article-title":"H7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25 degrees C storage","volume":"13","author":"TZ Chang","year":"2018","journal-title":"PloS one"},{"issue":"3","key":"ppat.1011514.ref078","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2011.02.026","article-title":"Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization","volume":"152","author":"X Chen","year":"2011","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"issue":"11","key":"ppat.1011514.ref079","doi-asserted-by":"crossref","first-page":"e0164692","DOI":"10.1371\/journal.pone.0164692","article-title":"Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation","volume":"11","author":"A Flood","year":"2016","journal-title":"PloS one"},{"issue":"44","key":"ppat.1011514.ref080","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2015.09.029","article-title":"Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate","volume":"33","author":"DG Rhodes","year":"2015","journal-title":"Vaccine"},{"issue":"28","key":"ppat.1011514.ref081","doi-asserted-by":"crossref","first-page":"11440","DOI":"10.1073\/pnas.1101414108","article-title":"Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures","volume":"108","author":"A Harris","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6244","key":"ppat.1011514.ref082","doi-asserted-by":"crossref","first-page":"aac4223","DOI":"10.1126\/science.aac4223","article-title":"HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"RW Sanders","year":"2015","journal-title":"Science"},{"issue":"1","key":"ppat.1011514.ref083","doi-asserted-by":"crossref","first-page":"15701","DOI":"10.1038\/s41598-018-34171-7","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"RN Kirchdoerfer","year":"2018","journal-title":"Scientific reports"},{"issue":"35","key":"ppat.1011514.ref084","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"J Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1011514.ref085","article-title":"An mRNA Vaccine against SARS-CoV-2\u2014Preliminary Report","author":"LA Jackson","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"ppat.1011514.ref086","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"D Wrapp","year":"2020","journal-title":"Cell"},{"issue":"1","key":"ppat.1011514.ref087","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/s41598-018-26538-7","article-title":"Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera","volume":"8","author":"HM Yassine","year":"2018","journal-title":"Scientific reports"},{"issue":"3","key":"ppat.1011514.ref088","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"L Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"ppat.1011514.ref089","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","article-title":"Characterization of nanoparticles-based vaccines for COVID-19","volume":"17","author":"G Guerrini","year":"2022","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"ppat.1011514.ref090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erv.12.140","article-title":"The history of MF59((R)) adjuvant: a phoenix that arose from the ashes","volume":"12","author":"DT O\u2019Hagan","year":"2013","journal-title":"Expert review of vaccines"},{"issue":"42","key":"ppat.1011514.ref091","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.vaccine.2019.08.030","article-title":"Comparison of adjuvants to optimize influenza neutralizing antibody responses","volume":"37","author":"RS Rudicell","year":"2019","journal-title":"Vaccine"},{"issue":"9","key":"ppat.1011514.ref092","doi-asserted-by":"crossref","DOI":"10.3390\/v10090461","article-title":"The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses","volume":"10","author":"TC Sutton","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"ppat.1011514.ref093","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41467-023-37162-z","article-title":"Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies","volume":"14","author":"ML Myers","year":"2023","journal-title":"Nature communications"},{"key":"ppat.1011514.ref094","doi-asserted-by":"crossref","first-page":"1002286","DOI":"10.3389\/fimmu.2022.1002286","article-title":"Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus","volume":"13","author":"ML Myers","year":"2022","journal-title":"Frontiers in immunology"},{"issue":"1\u20132","key":"ppat.1011514.ref095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"A Frey","year":"1998","journal-title":"Journal of immunological methods"},{"issue":"8","key":"ppat.1011514.ref096","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/JVI.03422-13","article-title":"Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages","volume":"88","author":"JR Whittle","year":"2014","journal-title":"J Virol"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1011514","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T14:07:41Z","timestamp":1694182061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011514"}},"subtitle":[],"editor":[{"given":"Peter","family":"Palese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":96,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011514","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/707984","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}